Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply

Andrew N.J. Tutt, Judy E. Garber, Charles E. Geyer

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1440
Number of pages1
JournalThe New England journal of medicine
Issue number15
StatePublished - Oct 7 2021


  • Breast Neoplasms/drug therapy
  • Female
  • Humans
  • Phthalazines/therapeutic use
  • Piperazines/therapeutic use

ASJC Scopus subject areas

  • Medicine(all)

Cite this